1. Home
  2. CNOB vs ANIP Comparison

CNOB vs ANIP Comparison

Compare CNOB & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConnectOne Bancorp Inc.

CNOB

ConnectOne Bancorp Inc.

N/A

Current Price

$32.19

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$74.17

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNOB
ANIP
Founded
1982
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
CNOB
ANIP
Price
$32.19
$74.17
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$31.25
$110.00
AVG Volume (30 Days)
379.7K
342.7K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
2.48%
N/A
EPS Growth
N/A
419.23
EPS
1.51
2.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$42.85
$21.01
Revenue Next Year
$7.27
$17.59
P/E Ratio
$21.37
$32.48
Revenue Growth
N/A
2.47
52 Week Low
$23.20
$70.15
52 Week High
$34.14
$99.50

Technical Indicators

Market Signals
Indicator
CNOB
ANIP
Relative Strength Index (RSI) 44.09 39.03
Support Level $31.36 N/A
Resistance Level $33.95 $83.43
Average True Range (ATR) 0.52 2.55
MACD -0.13 -0.13
Stochastic Oscillator 23.18 9.26

Price Performance

Historical Comparison
CNOB
ANIP

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: